je.st
news
Tag: hiv
Southern Research Continues 24 Years Of HIV Work With New NIH Contract
2014-12-03 07:24:53| drugdiscoveryonline News Articles
Southern Research has been awarded a $24 million, seven-year contract with the Division of AIDS, part of the National Institutes of Health, to provide drug discovery and development services to develop products that have the potential to become drugs for the treatment and prevention of HIV
Tags: years
work
research
contract
Mylan in deal for drug to treat HIV in developing countries
2014-12-01 16:52:37| Biotech - Topix.net
Mylan Inc. has reached a deal with Gilead Sciences Inc. for an HIV treatment in developing countries.
Tags: deal
countries
drug
developing
Merck Announces Data from 48-Week Phase 2b Study of Investigational HIV Therapy Doravirine (MK-1439) in Treatment-Naive Patients
2014-11-03 11:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Phase 3 Clinical Trial Enrollment Scheduled to Start by the End of 2014 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once-daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection. Results were presented as a poster (#0434) and oral presentation by Dr. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orCarmen de Gourville, 267-664-0146orInvestors:Joseph Romanelli, 908-423-5185orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
study
phase
patients
Dissolvable fabric loaded with medicine might offer protection against HIV
2014-07-30 21:48:11| Biotech - Topix.net
Univ. of Washington bioengineers have discovered a potentially faster way to deliver a topical drug that protects women from contracting HIV.
Tags: offer
protection
medicine
loaded
EGPAF applauds new licensing agreement to improve access to HIV medication for children
2014-07-27 05:05:44| Biotech - Topix.net
The Elizabeth Glaser Pediatric AIDS Foundation applauds the new licensing agreement between the Medicines Patent Pool and Gilead Sciences, Inc. to improve access to tenofovir alafenamide fumarate , a promising new HIV medication.
Tags: access
children
agreement
improve
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] next »